Basilea Buoyant As Antibiotic Finally Gets US Nod

 
• By Kevin Grogan
  
David Veitch
CEO David Veitch • Source: Basilea
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Anti-infective

More from Therapy Areas